Aimovig: A Breakthrough Migraine Medication

Print icon

A new medication recently approved by the FDA for the prevention of migraine headache is offering promising results for patients who suffer from these debilitating headaches. Dr. Abigail Chua, a neurologist and headache specialist at the Hartford HealthCare Headache Center has more on this groundbreaking new therapy. 

Q: Tell us about the recent FDA-approved medication for migraine treatment.

A: Aimovig is a migraine treatment in a new class of medications called CGRP monoclonal antibodies. This medication has been FDA-approved for the preventive treatment of migraine, and acts by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks.

Q: Why is this medication unique?

Prior to the development of CGRP-monoclonal antibodies, all of the preventives we were using for migraine were originally developed to treat other medical conditions, such as high blood pressure, depression, and epilepsy. While these medications can certainly be effective for a lot of people with migraine, not everyone can tolerate these medications, and some get no relief from them at all. Aimovig is the first medication available on the market that is designed to specifically target a protein that has been shown to be very closely tied to the development of migraine headaches.

Q: What type of patient would benefit most from this medication?

Patients who have migraine and have tried at least 2 other preventive treatments for migraine may be qualified to try this new medication.

Q: What kind of benefit can people expect from this new medication?

Aimovig is a migraine preventive treatment, and the goal of all migraine preventives is to decrease the frequency, severity, or duration of headaches. Depending on how often a person is having headaches, they may see a decrease in their headache frequency anywhere from 2 to 8 days per month, on average. Over the course of 12 months, this can mean 24 to 100 headache-free days per year.

For more information about the personalized migraine and head pain treatment available at Hartford HealthCare Headache Center, visit here


What's New


Applying Precision Medicine to Treat Your Cancer

As many as 38 out of every 100 women will get cancer in her lifetime – yet there is tremendous hope in the world of cancer research and treatment. Dr. Michael Kane is an expert on treating women’s cancers with the Hartford HealthCare Cancer Institute.  Q: As the charter member...

HPV Vaccine

New HPV Vaccine Offers Some Protection Against Several Cancers

Like many things in science and medicine, the vaccine for the human papilloma virus has evolved. First it was recommended for females age 12 to 26 who had not been sexually active, later for males in the same age group who had not had sex. Recently, however, research prompted the...


This Simple Saliva Test Assesses Breast Cancer Risk

By Meghan Burgess Breast cancer has a particularly high prevalence in Connecticut, but a new program is helping women and men identify their risk of developing the disease – and other cancers – through a simple questionnaire and saliva test. The Hereditary Cancer Risk Assessment Program, offered through Hartford HealthCare...


Upcoming Classes and Events in October and November

For a complete list of upcoming classes and events, please visit our Hartford HealthCare Classes and Events page. Upcoming Events Conditions Affecting the Hand Oct. 17 at 6:30pm in Simsbury To register, call 1.855.HHC.HERE or register online Lunch & Learn: Adjusting to Change as a Senior Oct. 18 at 12 noon in Southington To...

Dr. Camelia Lawrence

A ‘Bit of Anxiety’ Over This Physician’s First Mammogram, at 40

Dr. Camelia Lawrence took the proverb “physician, heal thyself” quite seriously when she donned a johnny recently and stepped up to a machine in The Hospital of Central Connecticut radiology suite in Plainville recently for her first screening mammogram. She just turned 40 and, as director of breast surgery for...


“Hidden Scar” Surgery: Making a Difference for Breast Cancer Patients

Breast surgeons at the Hartford HealthCare Cancer Institute at Hartford Hospital are performing a revolutionary procedure that allows them to do specific types of breast cancer surgery without leaving visible marks. Dr. Heather King is a breast surgeon with the Hartford HealthCare Cancer Institute to describe how this technique is...